Search

Your search keyword '"Berdel, Wolfgang E"' showing total 85 results

Search Constraints

Start Over You searched for: Author "Berdel, Wolfgang E" Remove constraint Author: "Berdel, Wolfgang E" Database Springer Nature Journals Remove constraint Database: Springer Nature Journals
85 results on '"Berdel, Wolfgang E"'

Search Results

3. Prognostic impact of CEBPA mutational subgroups in adult AML

4. Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)

5. Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia

6. Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

7. CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process

8. UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome

9. Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles

10. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome

12. Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study

13. A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy

14. Targeted siRNA nanocarrier: a platform technology for cancer treatment

15. Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

16. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

17. Electrostatic anti-CD33-antibody–protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia

21. Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response

22. Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia

23. Author Correction: Loss-of-function uORF mutations in human malignancies

25. Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia

26. Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia

27. The clinical mutatome of core binding factor leukemia

28. The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia

30. Favorable radiation field decrease in gastric marginal zone lymphoma: Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL)

31. Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)

35. Loss-of-function uORF mutations in human malignancies

38. A 17-gene stemness score for rapid determination of risk in acute leukaemia

39. Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia

42. Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML

48. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center

50. Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group

Catalog

Books, media, physical & digital resources